Toshiko Jobo

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Noriyuki Katsumata, Makoto Yasuda, Fumiaki Takahashi et al. · The Lancet · 2009 · 733 citations

Medicine, Oncology, Pharmacology +12

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 481 citations

Medicine, Gynecology, Oncology +13

Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma--a case report.

Mamiko Takaya, Yuzuru Niibe, Shinpei Tsunoda et al. · PubMed · 2007 · 68 citations

Medicine, Oncology, Radiation Oncology +16

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Hiroyuki Nomura, Daisuke Aoki, Fumiaki Takahashi et al. · Annals of Oncology · 2010 · 62 citations · Full text

Medicine, Gynecology, Oncology +8

Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma

Tomoyuki Miyamoto, Jun Watanabe, Hiroki Hata et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2004 · 61 citations

Medicine, Gynecology, Oncology +14